实用临床医药杂志2024,Vol.28Issue(9) :129-133.DOI:10.7619/jcmp.20240557

宏基因组二代测序诊断免疫缺陷患者感染性疾病的研究进展

Research progress of infectious diseases in immunocompromised hosts using metagenomic next generation sequencing-based diagnostics

杨震宇 於江泉
实用临床医药杂志2024,Vol.28Issue(9) :129-133.DOI:10.7619/jcmp.20240557

宏基因组二代测序诊断免疫缺陷患者感染性疾病的研究进展

Research progress of infectious diseases in immunocompromised hosts using metagenomic next generation sequencing-based diagnostics

杨震宇 1於江泉2
扫码查看

作者信息

  • 1. 扬州大学,江苏扬州,225009;扬州大学第七临床医学院/靖江市人民医院急诊科,江苏靖江,214500
  • 2. 扬州大学临床医学院/扬州大学附属苏北人民医院重症医学科,江苏扬州,225000
  • 折叠

摘要

宏基因组二代测序(mNGS)通过识别临床样本中的微生物核酸来协助诊断,是用于免疫功能低下患者感染性疾病诊断的有效工具.mNGS能够在常规检测为阴性的患者中识别出致病生物体,但目前在免疫力低下患者中,评估mNGS诊断感染效能的报告仅限于个体患者或小型回顾性研究.本文回顾分析文献,为在临床中开展mNGS相关研究提供新思路.

Abstract

Metagenomic next generation sequencing(mNGS)based diagnostics that identify mi-crobial nucleic acids in clinical samples may be a useful tool in addressing some of these challenges.Studies of mNGS in immunocompromised hosts have demonstrated that these diagnostics are capable of identifying causative organisms in a subset of patients for whom conventional testing has been negative.But the reports evaluating the diagnostic efficiency of mNGS in immunocompromised patients are limit-ed to individual patients or small retrospective studies at present.This article reviewed and analyzed the literature to provide new ideas for conducting related research on mNGS in clinical practice.

关键词

免疫功能不全/感染性疾病/病原体/宏基因组二代测序/液体活检/感染监测

Key words

immune dysfunction/infectious diseases/pathogens/metagenomic next generation sequencing/liquid biopsy/infection surveillance

引用本文复制引用

基金项目

江苏省医学重点学科建设单位基金(十四五)(JSDW202217)

江苏省扬州市社会发展项目(YZ2023105)

出版年

2024
实用临床医药杂志
扬州大学,中国高校科技期刊研究会

实用临床医药杂志

CSTPCD
影响因子:1.543
ISSN:1672-2353
参考文献量33
段落导航相关论文